Remicade is a brand name of infliximab, an artificial antibody. As a chimeric monoclonal antibody, it is a biologic drug composed of human and mice antibody amino acid sequences.
Here’s a list of Remicade prices:
Dosage | Without Insurance |
|---|---|
CVS Pharmacy |
|
| 100mg (3 Vials) | $2,577.55 |
| 100mg (6 Vials) | $5,303.33 |
| 100mg (9 Vials) | $7,769.95 |
Kmart |
|
| 100mg (3 Vials) | $2,624.33 |
| 100mg (6 Vials) | $5,242.67 |
| 100mg (9 Vials) | $7,865.00 |
Kroger |
|
| 100mg (3 Vials) | $2,595.40 |
| 100mg (6 Vials) | $5,302.82 |
| 100mg (9 Vials) | $7,951.60 |
Publix |
|
| 100mg (3 Vials) | $2,594.70 |
| 100mg (6 Vials) | $5,182.60 |
| 100mg (9 Vials) | $7,770.50 |
Rite Aid |
|
| 100mg (3 Vials) | $2,646.05 |
| 100mg (6 Vials) | $5,285.10 |
| 100mg (9 Vials) | $7,924.15 |
Target |
|
| 100mg (3 Vials) | $2,607.33 |
| 100mg (6 Vials) | $5,207.41 |
| 100mg (9 Vials) | $7,770.45 |
Walgreens |
|
| 100mg (3 Vials) | $2,642.19 |
| 100mg (6 Vials) | $5,275.82 |
| 100mg (9 Vials) | $7,909.57 |
Walmart |
|
| 100mg (3 Vials) | $5,277.55 |
| 100mg (6 Vials) | $5,150.11 |
| 100mg (9 Vials) | $7,725.66 |
History
The active ingredient, infliximab, was initially developed by Junming Le and Jan Vilcek at the New York University School of Medicine. It was subsequently developed for medical uses by Centocor, now known as Janssen Biotech, Inc.
Medical Uses
Remicade is used in the treatment and management of several types of autoimmune diseases including:
- Arthritis including rheumatoid arthritis, psoriatic arthritis, and arthritis of the spine
- Bowel diseases particularly ulcerative colitis and Crohn’s disease
- Severe skin diseases like chronic plaque psoriasis
In autoimmune diseases, the body’s immune system attacks its own healthy tissues resulting in a wide range of symptoms. The drug works by blocking the tumor necrosis factor alpha (TNF-α) substance in the body and, thus, reducing the inflammation. By weakening the offensive action of the immune system against the body, the drug either stops or slows down the damage caused by the disease.
Remicade cannot be administered orally since the digestive system will destroy the drug and, thus, render it useless. Instead, it’s administered via intravenous infusion, usually in intervals of six to eight weeks depending on the patient’s medical condition and drug response.
In a typical program, the drug can be administered two weeks after the first round with the third round given after 6 weeks. The succeeding doses can be given every 6 to 8 weeks depending on the medical issue.
Warning/Precaution
The intravenous infusion can last for at least two hours. It can be done at home but proper care is always a must for safety reasons.
Use the medication regularly and properly to enjoy the most benefit from its administration.
